Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Effects of endocrine-disrupting chemicals potentially serious, but difficult to prove
-
- Education and support shape the future of diabetes care Linda Siminerio, RN, PhD
- Advances in imaging technologies improve screening, detection of diabetic eye disease
- Survey: People with diabetes uncertain about management of hypoglycemia
- A conversation with Samuel Dagogo-Jack, MD Samuel Dagogo-Jack, MD
- Biosimilars Are Not Generics Richard O. Dolinar, MD
- What to do when a patient refuses insulin injections Ronald Tamler, MD, PhD, MBA
- FDA allows marketing of first CGM mobile medical apps
- Afrezza now available in US
-
- FDA approves Lenvima for progressive differentiated thyroid cancer
- Glyxambi approved for glycemic control
- Thyroid cysts not always benign Stephanie L. Lee, MD, PhD, ECNU
- CV risk in women with type 1 diabetes nearly double that in men
- ATRX mutation possible biomarker for rare neuroendocrine tumors
- Benefits of bariatric surgery decrease as BMI increases
- Bioavailable testosterone affected fat distribution during menopause
- BP reduction in type 2 diabetes may lower CVD risks at levels below guideline recommendations
-
- Deaths from lack of exercise double those from obesity
- Diabetes drug adherence drops with cancer diagnoses
- Diet, exercise alone not sufficient obesity treatment for most
- EDC exposure may lead to early menopause
- Gastric bypass improves survival for obese patients with and without diabetes
- Health care utilization among adults diagnosed with diabetes differs by age
- Hormone replacement therapy increases risk for ovarian cancer
- Insulin resistance-related lipoproteins linked to diabetes risk
-
- Insulin sensitivity, beta-cell function parameters could help characterize gestational diabetes
- Long-term hormonal contraceptive use linked to increased brain tumor risk
- Mortality risk decreased after bariatric surgery
- Napping could reverse health consequences of sleep debt
- Oral octreotide safe, effective as monotherapy for acromegaly in phase 3 trial
- Peer mentoring may improve diabetes management among adolescents
- Safety of Onglyza unaltered by kidney function
- Same mortality risk seen with HbA1c levels in prediabetes, normoglycemia
-
- Self-management improved depressive symptoms related to diabetes
- Tyrosine amino acids potential targets for diabetes treatment in South Asian men